文献速递治疗药物监测与药物基因组学

学术医疗中心药物基因组学实施 multifaceted 项目的开发:实践考量与经验教训

Development of a Multifaceted Program for Pharmacogenetics Adoption at an Academic Medical Center: Practical Considerations and Lessons Learned.
PubMed 文献 · Clin Pharmacol Ther · 2024-08-21

2019年印第安纳大学启动精准健康计划,旨在促进药物基因组学(PGx)在常规临床中的可持续应用。该项目通过整合PGx检测、实施高证据等级药物-基因对、教育医护人员、优化结果返回、减少健康差异及追踪第三方报销等举措,总结了实施中的挑战与成功经验,以帮助其他临床团队实现可持续的PGx实施。

要点

  • 将PGx检测整合到现有医疗系统流程中是实现可持续实施的关键。
  • 优先实施具有高证据等级的药物-基因对,并对医生和药师进行临床管理推荐的教育。
  • 关注患者参与、结果返回优化、减少健康差异及追踪第三方报销。

核心结论

  • 多层面PGx实施项目可促进基因导向处方在常规临床中的可持续采纳。

研究设计与样本

  • 2019年印第安纳大学启动精准健康计划,在印第安纳州大学附属实践点实施PGx项目,具体方法包括整合检测、教育、利益相关者参与、减少健康差异和追踪报销。

主要发现

  • 项目描述了实施的干预措施、面临的关键挑战和主要项目成功。

临床怎么用

  • 其他临床团队可借鉴该经验在各自医疗系统中实现可持续的PGx实施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In 2019, Indiana University launched the Precision Health Initiative to enhance the institutional adoption of precision medicine, including pharmacogenetics (PGx) implementation, at university-affiliated practice sites across Indiana. The overarching goal of this PGx implementation program was to facilitate the sustainable adoption of genotype-guided prescribing into routine clinical care. To accomplish this goal, we pursued the following specific objectives: (i) to integrate PGx testing into existing healthcare system processes; (ii) to implement drug-gene pairs with high-level evidence and educate providers and pharmacists on established clinical management recommendations; (iii) to engage key stakeholders, including patients to optimize the return of results for PGx testing; (iv) to reduce health disparities through the targeted inclusion of underrepresented populations; (v) and to track third-party reimbursement. This tutorial details our multifaceted PGx implementation program, including descriptions of our interventions, the critical challenges faced, and the major program successes. By describing our experience, we aim to assist other clinical teams in achieving sustainable PGx implementation in their health systems.

来源:Clin Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Shugg T, Tillman EM, Breman AM, et al. Development of a Multifaceted Program for Pharmacogenetics Adoption at an Academic Medical Center: Practical Considerations and Lessons Learned. Clin Pharmacol Ther. 2024. PMID: 39169556. doi:10.1002/cpt.3402

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。